19 July 2022 

“Since the first treatment for gonorrhoea became widely available in the 1930s, the bacteria has built up resistance to seven types of antibiotics, rendering them all almost completely useless. Only one treatment course remains for the sexually transmitted infection, which can be traced back to the earliest records of human history and generated 82mn cases globally in 2020, according to World Health Organization data.” 

The Financial Times interviewed Seamus O’Brien, Director of Research and Development at GARDP, about its work to develop a new antibiotic for gonorrhoea, zoliflodacin.